Search
for
Sort by
Research 121–150 of 1000+
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma
- Phenotypic variation in biotinidase deficiency
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Cutaneous lupus erythematosus: a review
- The spectrum of cutaneous manifestations in lupus erythematosus—the Italian experience
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Partial biotinidase deficiency: Clinical and biochemical features
- Dermatitis as a Presenting Sign of Cystic Fibrosis
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Lead, Mercury, and Arsenic Poisoning Due to Topical Use of Traditional Chinese Medicines
- Clinical and immunological manifestations in 151 SLE patients living in Dubai
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Biotin deficiency complicating parenteral alimentation: Diagnosis, metabolic repercussions, and treatment
- Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature
- Biotin Deficiency in an Infant Fed with Amino Acid Formula
- Pubic Hair Removal—Pearls and Pitfalls
- Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures
- Six-year Retrospective Review of Drug Reaction with Eosinophilia and Systemic Symptoms
- Associated Variables of Myositis in Systemic Lupus Erythematosus: A Cross-Sectional Study
- Toxic shock syndrome: Recent developments in pathogenesis
- Systemic Lupus Erythematosus
- COVID‐19 and dermatology: a comprehensive guide for dermatologists
- The Clinical Presentation of Systemic Lupus Erythematosus
- Dermatoses of pregnancy
- Thyroid hormone action in epidermal development and homeostasis and its implications in the pathophysiology of the skin
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Vitamin A toxicity: When one a day doesn't keep the doctor away
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs